Search Results
Jun 23, 2025, 19:10 ET HIMS INVESTIGATION ALERT: Investigation Launched into Hims & Hers Health, Inc., Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm
Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Hims & Hers Health, Inc. (NYSE: HIMS) focused on whether Hims & Hers and certain of its top executives made false and/or misleading statements and/or failed to disclose material
More news about: Robbins Geller Rudman & Dowd LLP
Jun 23, 2025, 08:03 ET Novo Nordisk terminates collaboration with Hims & Hers Health, Inc. due to concerns about their illegal mass compounding and deceptive marketing
2025 /PRNewswire/ -- Novo Nordisk announced today that the company will no longer be working with Hims & Hers Health, Inc., and that direct access to Wegovy® will no longer be available to Hims & Hers Health, Inc. via NovoCare® Pharmacy. In late April, the FDA resolved
More news about: NOVO NORDISK INC.
Jun 11, 2025, 10:20 ET 22.2% CAGR, Digital Health Market Size Worth $946.04 Billion Growth, Globally, by 2030 - Exclusive Study by The Research Insights
Telefónica S.A.Epic Systems CorporationQSI Management, LLCAT&TAirStrip TechnologiesGoogle, Inc.Hims & Hers Health, Inc.OrangeSoftserveComputer Programs and Systems, Inc.Vocera CommunicationsIBM CorporationCISCO
More news about: The Research Insights